Most Recent
KPMG slams Arrium class action’s ‘intuitive’ loss case
KPMG has told a judge there is no evidence that Arrium's share price would have changed even if it had recorded a $2.8 billion impairment, urging the judge to reject the shareholder class action's "intuitive" case on loss. 
Arrium directors deny class action claims they were ‘asleep at the wheel’
Former directors of steelmaker Arrium have rejected shareholder class action claims that the company's collapse was foreseeable, calling claims they had their heads in the sand “arrant nonsense”. 
KPMG failed to square contradictory evidence in Arrium accounts, court told
KPMG failed to bring the necessary scepticism to the task of auditing failing steel manufacturer Arrium, instead leaving contradictory evidence unresolved and giving the company a clean bill of health, a shareholder class action has told the court.
‘Systemic overoptimism’ left $2B impairment off Arrium books, court told
A shareholder class action against KPMG and ex-Arrium directors says the company's accounts were infected by "chronic and systemic overoptimism", with the former operator of Whyalla Steelworks portraying as viable a business that was impaired up to $2.8 billion.
Construction PRO
Trial delayed in Villawood fraud suit over Wallan development
A trial in related cases by developer Villawood over a logistics estate near Wallan, Victoria has been pushed back to next year.
CPE Capital wins $96M in dispute over profit-sharing agreement
A judge has awarded private equity firm CPE Capital, formerly CHAMP, $96 million in a dispute over a profit sharing agreement that was part of a deal to provide $150 million in vendor finance to FX Group Holdings for shares in trading platform Pepperstone.
Construction PRO
Villawood exec’s daughter claims privilege over ‘double deletion’ of docs
The daughter of a Villawood director accused of a fraudulent design to divert valuable management fees for a development in Victoria has invoked her privilege against self-incrimination over the developer’s concerns that she may have destroyed evidence. 
Suit accuses Telix of breaching licence agreement for cancer drug Zircaix
German pharmaceutical company Heidelberg Pharma has filed a lawsuit against Australian drug maker Telix alleging breach of a licence agreement for its kidney cancer diagnostic drug Zircaix. 
‘Nothing to do with us’: ESSSuper board hits back at $40M class action
The board administering the ESSSuper fund, which is facing a class action alleging it miscalculated the entitlements of transport shift workers in Victoria, has denied any liability, saying it was not involved in determining how entitlements were calculated.
Privilege waiver over Clifford Chance email doesn’t open door to discovery: court
An email to lawyers at Clifford Chance relied on to show investor Fiona Lock’s understanding of a contested $150 million profit sharing deal with trading platform Pepperstone did not open the door to further correspondence.